Status:
COMPLETED
WENBIT - Western Norway B Vitamin Intervention Trial
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
The Research Council of Norway
Norwegian Foundation for Health and Rehabilitation
Conditions:
Coronary Artery Disease
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
PURPOSE OF STUDY Observational studies have demonstrated that elevated levels of plasma total homocysteine is a risk factor for cardiovascular disease. The purpose of this trial is to evaluate the cli...
Detailed Description
BACKGROUND Coronary artery disease (CAD) is one of our common diseases, and despite the decline in mortality from acute coronary syndromes in the Western world, CAD remains the most important cause of...
Eligibility Criteria
Inclusion
- adults ≥ 18 years able to give informed consent
- patients prepared to undergo long-term follow-up
- patients with and without significant coronary artery disease (CAD) who have undergone coronary angiography just before inclusion
Exclusion
- patients who are not available for follow-up
- patients who have previously participated in this study
- patients with known alcohol abuse or serious mental illness
- patients with known active malignant disease
- patients who have undergone coronary angiography for specific reasons, i.e. assessment for cardiac transplantation, kidney donor, heart donor, diagnostic assessment of cardiomyopathy
Key Trial Info
Start Date :
April 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
3096 Patients enrolled
Trial Details
Trial ID
NCT00354081
Start Date
April 1 1999
End Date
February 1 2008
Last Update
July 12 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Heart Disease, Haukeland University Hospital
Bergen, Bergen, Norway, 5021
2
Department of Cardiology, Stavanger University Hospital
Stavanger, Norway, 4011